Kane Biotech Inc. (CVE:KNE – Get Free Report) traded down 13.3% during mid-day trading on Friday . The stock traded as low as C$0.06 and last traded at C$0.07. 537,300 shares traded hands during mid-day trading, an increase of 855% from the average session volume of 56,261 shares. The stock had previously closed at C$0.08.
Kane Biotech Stock Down 7.7%
The company has a market cap of C$8.64 million, a P/E ratio of 1.50 and a beta of 0.52. The company has a current ratio of 0.80, a quick ratio of 0.39 and a debt-to-equity ratio of -331.42. The firm’s 50 day moving average price is C$0.09 and its 200-day moving average price is C$0.10.
About Kane Biotech
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.
Featured Articles
- Five stocks we like better than Kane Biotech
- Energy and Oil Stocks Explained
- Top 4 ETFs for China Exposure After Tariff Relief
- How to Use the MarketBeat Excel Dividend Calculator
- Build a Complete Bond Portfolio With These 4 ETFs
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- MarketBeat Week in Review – 05/12 – 05/16
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
